Document Detail


MultiHance in the dynamic phase of contrast enhancement: a pictorial assessment.
MedLine Citation:
PMID:  10608399     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The present article demonstrates pictorially the use of MultiHance (gadobenate dimeglumine, Gd-BOPTA) in dynamic magnetic resonance imaging and is aimed at ensuring that the product is not misconceived as solely a hepatobiliary agent for use in delayed, static magnetic resonance imaging for the improved detection of focal liver lesions. The enhancement patterns of three malignant (hepatocellular carcinoma, cholangiocarcinoma and metastasis) and three benign (hemangioma, focal nodular hyperplasia and adenoma) lesion types are demonstrated. Each was imaged during the dynamic phase of contrast enhancement immediately following the intravenous bolus administration of 0.05 mmol/kg MultiHance. The article demonstrates that the enhancement patterns observed for these relatively common lesions are similar to those reported in the literature after the intravenous bolus administration of conventional, non-specific 'extracellular fluid' contrast agents, and concludes by inferring that MultiHance behaves in the liver as a conventional gadolinium-based agent in the first minutes after administration.
Authors:
L Grazioli; M Kirchin; G Pirovano; A Spinazzi
Related Documents :
11387129 - Dynamic contrast-enhanced mr imaging for soft tissue sarcomas.
19406359 - Fundamentals of quantitative dynamic contrast-enhanced mr imaging.
12065119 - Application of dynamic mri to differentiating odontogenic myxomas from ameloblastomas.
6628409 - Dynamic ct of the chest.
19820949 - Dynamic contrast-enhanced mr imaging to assess physiologic variations of myometrial per...
6768269 - Dynamic cranial computed tomography: preliminary results.
14646039 - Assessment of cancer-associated biomarkers by positron emission tomography: advances an...
9129409 - Dual-phase helical ct of the liver: value of an early-phase acquisition in the differen...
8249719 - Serial ct in fibrosing alveolitis: prognostic significance of the initial pattern.
Publication Detail:
Type:  Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of computer assisted tomography     Volume:  23 Suppl 1     ISSN:  0363-8715     ISO Abbreviation:  J Comput Assist Tomogr     Publication Date:  1999 Nov 
Date Detail:
Created Date:  2000-01-05     Completed Date:  2000-01-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7703942     Medline TA:  J Comput Assist Tomogr     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S61-4     Citation Subset:  IM    
Affiliation:
Medical and Regulatory Affairs, Bracco SpA, Milano, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenoma / diagnosis
Bile Duct Neoplasms / diagnosis
Bile Ducts, Intrahepatic / pathology
Carcinoma, Hepatocellular / diagnosis
Cholangiocarcinoma
Contrast Media*
Diagnosis, Differential
Focal Nodular Hyperplasia / diagnosis
Gadolinium / diagnostic use*
Hemangioma / diagnosis
Humans
Injections, Intravenous
Liver Diseases / diagnosis*
Liver Neoplasms / diagnosis
Magnetic Resonance Imaging / methods*
Meglumine / administration & dosage,  analogs & derivatives*,  diagnostic use
Organometallic Compounds / administration & dosage,  diagnostic use*
Prospective Studies
Chemical
Reg. No./Substance:
0/Contrast Media; 0/Organometallic Compounds; 113662-23-0/gadobenic acid; 6284-40-8/Meglumine; 7440-54-2/Gadolinium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical utility and safety of MultiHance in magnetic resonance imaging of liver cancer: results of ...
Next Document:  Clinical late phase II trials of MultiHance (Gd-BOPTA) for the magnetic resonance imaging of liver t...